Using genome-wide association, we identify common variants at 2p12-p13, 6q26, 17q23 and 19q13 associated with serum creatinine, a marker of kidney function (P = 10 −10 to 10 −15 ). Of these, rs10206899 (near NAT8, 2p12-p13) and rs4805834 (near SLC7A9, 19q13) were also associated with chronic kidney disease (P = 5.0 × 10 −5 and P = 3.6 × 10 −4 , respectively). Our findings provide insight into metabolic, solute and drug-transport pathways underlying susceptibility to chronic kidney disease.
). In contrast, rs3127573 (6q26) and rs8068318 (17q23) were associated with eGFR but not with cystatin c or CKD. None of the four SNPs were associated with weight, hypertension, diabetes or other clinical parameters known to influence creatinine levels (Supplementary Table 5) , and the relationships of these SNPs with creatinine were similar among people with and without diabetes or hypertension (Supplementary Table 6 ).
rs10206899 (2p12-p13), which is associated with creatinine, eGFR, cystatin c and CKD, is near several genes, including NAT8, NAT8B, ALMS1, DUSP11 and TPRKB (Fig. 1) . NAT8 is a biologically compelling candidate for the observed association. NAT8 is a member of the GCN5-related N-acetyltransferase (GNAT) superfamily, a group of enzymes that catalyze transfer of an acetyl group from acetyl-coenzyme A to a wide range of acceptor substrates 6 . NAT8 is strongly and almost exclusively expressed in kidney (Supplementary Fig. 3 ), in particular by tubular cells of the renal cortex ( Supplementary Figs. 4 and 5) . Acetylation is a key metabolic pathway for the detoxification of nephrotoxic substances such as aminoglycosides, inhalational anesthetics and environmental toxins, including industrial solvents such as trichloroethylene 7, 8 . rs10206899 is in high LD (r 2 = 1.0) with the only common nonsynonymous SNP in NAT8, rs15358 (causing a A595G change). rs15358 produces a nonconservative amino acid change (F143S) within the acetyl-coenzyme A binding site, an effect predicted to influence acetylation by NAT8 ( Supplementary  Fig. 6 ). rs15358 was also closely associated with creatinine levels in the genome-wide study (P = 1.8 × 10 −8 ). Our findings raise the possibility that common genetic variation in NAT8 may influence acetylation pathways, disturbances of which are known to be associated with drug-and toxin-induced kidney injury.
NAT8B is highly homologous to NAT8 and also contains an acetyltransferase domain but is only expressed at low levels in kidney (Supplementary Fig. 3 ). Mutations in ALMS1 are responsible for Alström Syndrome, a rare autosomal-recessive multisystem disorder characterized by progressive kidney and hepatic failure, obesity and insulin resistance, and blindness and hearing loss 9 . Although DUSP11 and TPRKB are also near rs10206899, neither has been implicated in kidney function. DUSP11 is a dual-specificity protein phosphatase; TPRKB encodes the p53-related proteinkinase-binding protein and is of unknown function. Neither is strongly or preferentially expressed in kidney.
rs4805834 (19q13) is near SLC7A9, a cationic amino acid transporter highly expressed in kidney tubular cells (Supplementary Fig. 3 ) 10 . SLC7A9 is a strong candidate for the association of rs4805834 with creatinine, eGFR, cystatin c and CKD; mutations in SLC7A9 cause cystinuria and nephrolithiasis and are associated with increased risk of CKD 10 . rs4805834 is also near CCDC123 and C19orf40. The latter (also known as FAAP24) has been identified as a component of the Fanconi anemia core complex, which plays a crucial role in DNA damage response 11 but has no reported relationship to kidney function. The function of CCDC123 is not known. rs3127573 (6q26) and rs8068318 (17q23) were associated with creatinine and eGFR. rs3127573 is near SLC22A2, an organic cation transporter strongly and preferentially expressed in kidney (Supplementary Fig. 3 ) that contributes to secretion of creatinine and other substrates by renal tubular epithelial cells 12 . Common variants at this locus are reported to influence kidney injury caused by nephrotoxic drugs such as cisplatin 13 . rs8068318 is located in TBX2, which encodes a member of the highly conserved T-box family of transcription factors 14 . Mouse Tbx2 −/− mutants have a range of morphological defects, including limb deformities and cardiac anomalies, but a renal phenotype has not previously been described for them 14 . Tbx2 is widely expressed in many tissues, including developing and adult Alleles, reference allele/minor allele; MAF, minor allele frequency; GWA, genome-wide association; effect size, % change in serum creatinine (95% CI) or odds ratio for CKD (95% CI) per copy of minor allele under an additive genetic model and adjusted for (i) age, gender and principal component scores in the genome-wide association study and (ii) age and gender in the replication study. Effect sizes were estimated by meta-analysis of cohort-specific beta estimates using the inverse variance method and a fixed effects model. b r i e f c o m m u n i c a t i o n s kidneys 15 , but the function of Tbx2 in the kidney is not known. rs8068318 is also near BCAS3 and hypothetical gene C17orf82. BCAS3 may be involved in angiogenesis, but is not known to be involved in kidney function.
In addition to SHROOM3, we also replicated previously reported associations 2 of rs12917707 in UMOD (P = 1.7 × 10 −5 ) and rs2467853 in GATM (P = 6.0 × 10 −6 ) with creatinine in the genome-wide association study. Although we did not find a relationship of the MYH9 locus with creatinine, this may simply reflect the low prevalence (~4%) of the MYH9 risk haplotype in Europeans (Supplementary Methods) 3 .
Our findings of common genetic variants associated with creatinine, cystatin c and CKD provide insight into the metabolic, solute and drugtransport mechanisms underlying kidney function and CKD. Further evaluation of these pathways may enable biomarker discovery and the development of new strategies to protect kidney function and prevent CKD.
